| Double-expressor lymphoma is associated with poor outcomes after allogeneic hematopoietic cell transplantation I Kawashima, Y Inamoto, AM Maeshima, J Nomoto, K Tajima, T Honda, ... Biology of Blood and Marrow Transplantation 24 (2), 294-300, 2018 | 35 | 2018 |
| Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells I Kawashima, T Mitsumori, Y Nozaki, T Yamamoto, Y Shobu-Sueki, ... Experimental hematology 43 (7), 524-533. e1, 2015 | 34 | 2015 |
| Metformin inhibits JAK2V617F activity in MPN cells by activating AMPK and PP2A complexes containing the B56α subunit I Kawashima, K Kirito Experimental hematology 44 (12), 1156-1165. e4, 2016 | 32 | 2016 |
| Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma K Nakajima, I Kawashima, M Koshiisi, T Kumagai, M Suzuki, J Suzuki, ... Experimental Hematology 78, 46-55. e3, 2019 | 31 | 2019 |
| Safety and efficacy of anti-programmed cell death-1 monoclonal antibodies before and after allogeneic hematopoietic cell transplantation for relapsed or refractory Hodgkin … A Ito, SW Kim, K Matsuoka, T Kawakita, T Tanaka, Y Inamoto, T Toubai, ... International journal of hematology 112, 674-689, 2020 | 24 | 2020 |
| Rituximab activates Syk and AKT in CD20-positive B cell lymphoma cells dependent on cell membrane cholesterol levels Y Nozaki, T Mitsumori, T Yamamoto, I Kawashima, Y Shobu, S Hamanaka, ... Experimental hematology 41 (8), 687-696. e1, 2013 | 17 | 2013 |
| Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sources T Shichijo, S Fuji, K Tajima, H Kubo, K Nozaki, T Honda, J Yamaguchi, ... Bone Marrow Transplantation 53 (5), 634-639, 2018 | 13 | 2018 |
| Presence of bone marrow fibrosis in multiple myeloma may predict extramedullary disease M Koshiishi, I Kawashima, H Hyuga, A Nakadate, M Matsuura, ... International Journal of Hematology 116 (4), 544-552, 2022 | 12 | 2022 |
| Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells T Mitsumori, Y Nozaki, I Kawashima, T Yamamoto, Y Shobu, K Nakajima, ... Experimental hematology 42 (9), 783-792. e1, 2014 | 10 | 2014 |
| Bone marrow invasion of small cell neuroendocrine carcinoma of the endometrium: a diagnostic pitfall mimicking a haematological malignancy I Kawashima, H Fukasawa, K Kasai, T Kumagai, M Koshiishi, K Nakajima, ... Internal Medicine 58 (17), 2561-2568, 2019 | 8 | 2019 |
| Combined coagulopathy can induce both hemorrhagic and thrombotic complications in multiple myeloma I Kawashima, K Takano, T Kumagai, M Koshiishi, S Oishi, Y Sueki, ... Internal Medicine 57 (22), 3303-3306, 2018 | 8 | 2018 |
| Anaplastic large cell lymphoma with paraneoplastic neutrophilia: an association between IL-17 elevation and aggressive disease progression Y Sueki, Y Nozaki, I Kawashima, T Yamamoto, K Nakajima, T Mitumori, ... International journal of hematology 99, 773-776, 2014 | 7 | 2014 |
| Transdifferentiation of mantle cell lymphoma into sarcoma with limited neuromuscular differentiation after conventional chemotherapy I Kawashima, N Oishi, K Kasai, T Inoue, E Hosokawa, A Nakadate, ... Virchows Archiv, 1-5, 2022 | 6 | 2022 |
| 18F-FDG-PET/CT is effective in distinguishing myelofibrosis due to bone marrow infiltration of diffuse large B-cell lymphoma from triple-negative primary myelofibrosis. T Kumagai, Y Satoh, M Koshiishi, S Ooishi, Y Sueki, K Nakajima, ... [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology 58 (3), 228-232, 2017 | 6 | 2017 |
| Non-traumatic splenic rupture during the chemotherapy and successful management by emergency splenectomy in a patient with blastic plasmacytoid dendritic cell neoplasm I Kawashima, Y Sueki, T Yamamoto, S Hamanaka, Y Nozaki, K Nakajima, ... [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology 54 (6), 584-586, 2013 | 6 | 2013 |
| Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia–lymphoma A Onishi, S Fuji, S Kitano, AM Maeshima, K Tajima, J Yamaguchi, ... Annals of Hematology 101 (4), 799-810, 2022 | 5 | 2022 |
| Tumor lysis syndrome after the administration of ruxolitinib in a patient with post-polycythemia vera myelofibrosis M Koshiishi, Y Sueki, I Kawashima, K Nakajima, T Mitsumori, K Kirito Internal Medicine 56 (17), 2335-2338, 2017 | 4 | 2017 |
| Gastric invasion of multiple myeloma presenting as gastrointestinal bleeding K Nakajima, Y Sueki, M Koshiishi, I Kawashima, Y Nozaki, T Mitsumori, ... International Journal of Hematology 101, 525-526, 2015 | 4 | 2015 |
| Development of cytomegalovirus antigenemia in 3 patients with B cell lymphoma treated with bendamustine monotherapy T Mitsumori, Y Sueki, I Kawashima, T Yamamoto, Y Nozaki, K Nakajima, ... [Rinsho ketsueki] The Japanese journal of clinical hematology 55 (2), 239-243, 2014 | 4 | 2014 |
| Aberrant activation of NF-ΚB and hypoxia enhances glycolytic enzyme hexokinase II expression in B-cell lymphoma through activation of HIF-1 K Nakajima, K Kirito, I Kawashima, M Koshiishi, T Kumagai, T Mitsumori Blood 130, 4025, 2017 | 3 | 2017 |
